NCT04214639View on ClinicalTrials.gov

Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris

PHASE3CompletedINTERVENTIONAL
Enrollment

183

Participants

Timeline

Start Date

January 17, 2020

Primary Completion Date

January 18, 2021

Study Completion Date

January 18, 2021

Conditions
Acne Vulgaris
Interventions
DRUG

IDP-126 Gel

IDP-126 Gel applied topically to the face once daily for 12 weeks.

DRUG

IDP-126 Vehicle Gel

IDP-126 Vehicle Gel applied topically to the face once daily for 12 weeks.

Trial Locations (13)

10075

Bausch Site 114, New York

27262

Bausch Site 105, High Point

32771

Bausch Site 106, Sanford

33162

Bausch Site 111, North Miami Beach

33463

Bausch Site 102, Boynton Beach

37215

Bausch Site 107, Nashville

72022

Bausch Site 110, Bryant

78660

Bausch Site 108, Pflugerville

80220

Bausch Site 109, Denver

89148

Bausch Site 103, Las Vegas

94538

Bausch Site 104, Fremont

L4M 7G1

Bausch Site 101, Barrie

N2J 1C4

Bausch Site 113, Waterloo

All Listed Sponsors
lead

Bausch Health Americas, Inc.

INDUSTRY

NCT04214639 - Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris | Biotech Hunter | Biotech Hunter